Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.

Marina Baretti, MD, is an assistant professor at Johns Hopkins University School of Medicine and the Jiasheng Chair in Hepato-Biliary Cancer Research. She also serves as Co-Director of the Liver and Biliary Cancer Multidisciplinary Clinic at the Sidney Kimmel Comprehensive Cancer Center (SKCCC). Dr. Baretti received her medical degree from the University of Pisa in Italy. She completed her internal medicine residency and oncology fellowship at University of Milan. She then went on and completed her Postdoctoral and Medical Oncology Fellowship at Johns Hopkins University, Baltimore, Maryland. She is deeply engaged in bridging the gap between laboratory discoveries and clinical application, working closely with laboratory-based scientists to accelerate the development of novel therapeutic strategies. Her academic research is centered on the development of novel agents in hepatobiliary cancers, with particular interest in combinatorial approaches of immunotherapies. She is currently the principal investigator on multiple clinical trials in FLC, HCC and cholangiocarcinoma at Johns Hopkins University, collaborating closely with laboratory-based researchers to move laboratory findings into patients. Through her work, Dr. Baretti strives to improve outcomes for patients with rare GI cancers by identifying innovative therapies that are informed by a deeper understanding of tumor biology and the tumor microenvironment. Dr. Baretti was the recipient of the 2018 American Society of Clinical Oncology Young Investigator Award. Dr. Baretti was also awarded with the 2020 Career Development Award for the MD Anderson Cancer Center’s pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE). Dr. Baretti is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, and Pancreatic Cancer.

. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Lindsay King is a Hepatologist and a Transplant Surgeon in Durham, North Carolina. Dr. King is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Visceromegaly, Autoimmune Hepatitis, Enlarged Liver, and Hepatitis. Dr. King is currently accepting new patients.

Sabino Zani is a Surgical Oncologist in Durham, North Carolina. Dr. Zani is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Zani is currently accepting new patients.

Peter Allen is a General Surgeon and a Surgical Oncologist in Durham, North Carolina. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Small Bowel Resection, and Pancreatectomy. Dr. Allen is currently accepting new patients.

Matthew Howenstein is an Interventional Radiologist in Grafton, Wisconsin. Dr. Howenstein is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Thyroid Nodule, Lung Nodules, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Bone Graft.

Edward James is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. James is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Gastrostomy.

Manisha Palta is a Radiation Oncologist in Durham, North Carolina. Dr. Palta is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Ampullary Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Palta is currently accepting new patients.

Carla Brady is a Hepatologist and a Transplant Surgeon in Durham, North Carolina. Dr. Brady is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Hepatitis, Autoimmune Hepatitis, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, and Liver Transplant. Dr. Brady is currently accepting new patients.

Ghassan Abou-Alfa is an Oncologist in New York, New York. Dr. Abou-Alfa is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Liver Embolization, and Pancreaticoduodenectomy.

Ahmed Kaseb is an Oncologist in Houston, Texas. Dr. Kaseb is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepatectomy, and Liver Embolization.

John Gordan is an Oncologist and a Hematologist in San Francisco, California. Dr. Gordan has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Adenocarcinoma, Gallbladder Cancer, and Tissue Biopsy.

Raymond Yeung is a Surgical Oncologist and a General Surgeon in Seattle, Washington. Dr. Yeung has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Adenocarcinoma, and Hepatectomy. Dr. Yeung is currently accepting new patients.

Gadi Lalazar is a Gastroenterologist and a Hepatologist in New York, New York. Dr. Lalazar is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), and Liver Cancer.

Erik Schadde is a Transplant Surgeon in Madison, Wisconsin. Dr. Schadde is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Liver Cancer, Enlarged Liver, Hepatectomy, and Liver Embolization. Dr. Schadde is currently accepting new patients.

Jordan Tasse is an Interventional Radiologist and a Radiologist in Chicago, Illinois. Dr. Tasse is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Varicose Veins, Familial Pancreatic Cancer, Liver Embolization, and Angioplasty.

Annika Nelde practices in Tuebingen, Germany. Ms. Nelde is rated as an Elite expert by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Fibrolamellar Carcinoma, Leukemia, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

Yacine Maringer practices in Tuebingen, Germany. Maringer is rated as an Elite expert by MediFind in the treatment of Fibrolamellar Carcinoma. Their top areas of expertise are Fibrolamellar Carcinoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Leukemia.

David Lu is an Interventional Radiologist and a Radiologist in Manhattan Beach, California. Dr. Lu is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Visceromegaly, and Muscle Invasive Bladder Cancer.